Search

Your search keyword '"Justice SS"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Justice SS" Remove constraint Author: "Justice SS"
46 results on '"Justice SS"'

Search Results

1. Evaluating urine volume and host depletion methods to enable genome-resolved metagenomics of the urobiome.

2. Longitudinal examination of urine pH, specific gravity, protein, culture, and antimicrobial resistance profiles in healthy dogs.

3. The use of Escherichia coli strain Nissle 1917 shows promise for improving gastrointestinal and urinary health in dogs.

4. Escherichia coli probiotic exhibits in vitro growth-limiting effects on clinical feline uropathogenic E coli isolates.

5. Neutrophil-Macrophage Imbalance Drives the Development of Renal Scarring during Experimental Pyelonephritis.

6. Acquisition, Divergence, and Personalization of the Female Perineal Microbiomes Are Driven by Developmental Milestones and Disrupted by Urinary Tract Infection: A Pilot Study.

8. Continuous Microevolution Accelerates Disease Progression during Sequential Episodes of Infection.

9. Reprioritization of biofilm metabolism is associated with nutrient adaptation and long-term survival of Haemophilus influenzae .

11. Microevolution in response to transient heme-iron restriction enhances intracellular bacterial community development and persistence.

12. Transient Nutrient Deprivation Promotes Macropinocytosis-Dependent Intracellular Bacterial Community Development.

13. Inflammation drives renal scarring in experimental pyelonephritis.

14. Comparison of the microbiological milieu of patients randomized to either hydrophilic or conventional PVC catheters for clean intermittent catheterization.

15. Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment.

16. Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.

17. Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms.

18. DNABII proteins play a central role in UPEC biofilm structure.

19. Bacterial differentiation, development, and disease: mechanisms for survival.

20. An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract.

21. Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract.

22. Haemophilus responses to nutritional immunity: epigenetic and morphological contribution to biofilm architecture, invasion, persistence and disease severity.

23. Relationship among bacterial virulence, bladder dysfunction, vesicoureteral reflux and patterns of urinary tract infection in children.

24. SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus.

25. New paradigms of urinary tract infections: Implications for patient management.

26. UPEC hemolysin: more than just for making holes.

27. Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitis.

28. Aberrant community architecture and attenuated persistence of uropathogenic Escherichia coli in the absence of individual IHF subunits.

29. Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins.

30. In vitro analysis of the bactericidal activity of Escherichia coli Nissle 1917 against pediatric uropathogens.

31. Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract.

32. Novel management of urinary tract infections.

33. FIND: a new software tool and development platform for enhanced multicolor flow analysis.

34. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli.

36. SOS regulatory elements are essential for UPEC pathogenesis.

37. Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.

38. Morphological plasticity as a bacterial survival strategy.

39. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection.

40. Maturation of intracellular Escherichia coli communities requires SurA.

41. Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli.

42. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.

43. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

44. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.

45. Cell division inhibitors SulA and MinC/MinD block septum formation at different steps in the assembly of the Escherichia coli division machinery.

Catalog

Books, media, physical & digital resources